Sort
64,565 grants matching “drug discovery”
Indiana University Center for Pediatric Pharmacology
$765,284Jamie L Renbarger · Indiana University Indianapolis · U54 · FY2012 · HD
Membrane-active quinoline and quinazoline antibacterials that target Gram positive pathogens
$765,224Ambrose L. Cheung · Dartmouth College · R01 · FY2022 · AI
Molecular Imaging of G-Protein-Coupled Receptors for Drug Development
$765,204Stanley J Opella · University Of California, San Diego · R01 · FY2012 · EB
FMitF: Track I: Correct-by-Construction Synthesis of Microfluidic Chips
$765,137Manu Sridharan · University Of California-Riverside · · FY2020 · CSE
Host Defense Small Molecule Development for COVID-19 Treatment by Targeting Lysosome
$765,082Yuan Liu · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · AI
Harnessing Glycoproteomics and Glycomics to Understand Cardiac Biology and Disease
$765,000Rebekah L. Gundry · University Of Nebraska Medical Center · R35 · FY2021 · HL
Cancer Center Support Grant
$765,000Roy A. Jensen · University Of Kansas Medical Center · P30 · FY2020 · CA
Optimization and preclinical development of FAAH inhibitors for smoking cessation
$765,000Daniele Piomelli · University Of California-Irvine · DP1 · FY2010 · DA
Engineering biophysical microtechnologies for hematologic applications in health and disease
$764,994Wilbur A Lam · Emory University · R35 · FY2021 · HL
ADMINISTRATION (Admin Core)
$764,965Nancy E Davidson · University Of Pittsburgh At Pittsburgh · P30 · FY2016 · CA
Harnessing Glycoproteomics and Glycomics to Understand Cardiac Biology and Disease
$764,825Rebekah L. Gundry · University Of Nebraska Medical Center · R35 · FY2023 · HL
Screen Drugs for Radioprotective/Therapeutic Efficacy
$764,812Office Of The Director, National Institutes Of Health · Y01 · FY2010 · OD
Development of novel anti-Neisseria gonorrhoeae therapeutic agents
$764,773Daniel Patrick Flaherty · Purdue University · R01 · FY2023 · AI
Epigenetic Probes for HMTs
$764,740Haiching Ma · Reaction Biology Corporation · R44 · FY2017 · TR
Identification of small molecules for neurological complications of HIV and substance abuse comorbidity
$764,647Pietro P Sanna · Scripps Research Institute, The · R01 · FY2021 · DA
Membrane-active quinoline and quinazoline antibacterials that target Gram positive pathogens
$764,618Ambrose L. Cheung · Dartmouth College · R01 · FY2021 · AI
Broad Spectrum Bitter Taste Antagonists Discovery
$764,602Erik Mills Schwiebert · Discoverybiomed, Inc. · R42 · FY2021 · DC
Investigating the role of Alzheimer's disease familial mutations in neuromuscular physiology
$764,558James J Hickman · University Of Central Florida · R01 · FY2022 · AG
Structure-based drug discovery for Dopamine D2 Receptor Selective Ligands
$764,531Victoria Ahn · Confometrx, Inc. · R44 · FY2020 · MH
Immobilized Receptors In Drug Discovery
$764,513Irving William Wainer · National Institute On Aging · ZIA · FY2010 · AG
Atorvastatin Treatment of Cavernous Angiomas with Symptomatic Hemorrhage Exploratory Proof of Concept (AT CASH EPOC) Trial
$764,492Issam A Awad · University Of Chicago · R01 · FY2022 · NS
Clinical Protocol and Data Management/Clinical Trials Office (Core-015)
$764,384Vicki Leigh Keedy · Vanderbilt University · P30 · FY2015 · CA
Clinical Protocol and Data Management/Clinical Trials Office (Core-015)
$764,384Vicki Leigh Keedy · Vanderbilt University Medical Center · P30 · FY2016 · CA
Discovery and development of broad spectrum anti-flaviviral drugs
$764,373Mariano A. Garcia-Blanco · Duke University · R01 · FY2013 · AI
Genetics to Brain Biomarkers in Kynurenine Pathway Dysfunction
$764,303L. Elliot Hong · University Of Maryland Baltimore · P50 · FY2020 · MH